{"id":"W2113344831","doi":"10.1016/s1470-2045(09)70314-6","title":"Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial","year":2009,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1405,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Genomic Health; U.S. Department of Health and Human Services","keywords":"Tamoxifen; Medicine; Internal medicine; Breast cancer; Oncology; Hazard ratio; Proportional hazards model; Anthracycline; Chemotherapy; Cyclophosphamide; Retrospective cohort study; Gynecology; Cancer; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}